Quality of Life
Quality of life study for breast cancer patients experiencing neuropathy from chemotherapy
Study Contact Information:
Contact: Constance Visovsky by phone: 813-974-3831 or by email: [email protected]
Contact: Jillian Coury by phone: 8139745117 or by email: [email protected]
Chemotherapy-induced peripheral neuropathy (CIPN) symptoms include numbness combined with tingling sensations, persistent shooting, stabbing, or burning pain even in the absence of an obvious cause, lower extremity muscle weakness, and impaired balance. Resistance exercise has shown promising results; however, the effect of exercise on CIPN remains understudied. This study will look at the effects of gain and balance training and resistance exercise (using bands) on gait, balance, and lower extremity muscle strength after a 16-week home-based exercise program compared to educational materials without an exercise program.
Participants will be selected by chance to participate in one of the following groups:
Outcomes will be measured at the beginning of the study and at 16 weeks. Some outcomes are also measured at weeks 4, 8, and 12. Outcomes measured are gait change, balance change, change in lower extremity muscle strength, change in lower extremity nerve conduction, change in neuropathy symptoms, and neuropathy quality of life.
Female breast cancer survivors (>21) who completed treatment for invasive breast cancer with taxane-based chemotherapy, and who have a peripheral neuropathy (as rated based on a test known as a VAS score).
*contact your doctors or the study coordinators for questions about inclusion criteria.
People with the following are not eligible:
*contact your doctors or the study coordinators for questions about exclusion criteria.
FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.